Levetiracetam Tecnigen (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This interaction decreases excessive neuronal firing, thereby lowering the likelihood of seizure generation across various seizure types.

The appropriate dose of Levetiracetam Tecnigen is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are made to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy are limited, and the drug is classified as pregnancy category unknown. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancing agents such as valproate. It generally has fewer drug‑enzyme interactions, but clinicians consider individual patient factors when selecting the most appropriate therapy.

Store Levetiracetam Tecnigen tablets at ambient temperature below 25 °C. Keep the product in its original container, protect it from moisture, and avoid exposure to direct sunlight to maintain potency throughout its shelf life.

Levetiracetam Tecnigen is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include severe allergic reactions (e.g., Stevens‑Johnson syndrome), mood disturbances such as depression or suicidal thoughts, and rare hematologic abnormalities. Patients should seek immediate medical attention if they experience rash, mood changes, or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that markedly reduce its plasma levels.